Over a week ago |
On The Fly
| ShowHide Related Items >><< - 12/17/20
- Zynerba announces development plan for Zygel
- 12/17/20
- Zynerba provides regulatory update on Zygel in Fragile X syndrome
- 12/10/20
- Immunome appoints Richard Baron to board, Stoneman as Chief Legal Officer
- $18.01 /
+2.985 (+19.87%) - 12/15/20
- Tilray up 8%, Aphria up 2% after merger speculation reported by Bloomberg
IGC India Globalization Capital - 11/23/20
- IGC commences Phase 1 of cannabinoid trial for Alzheimer's patients
- 11/23/20
- IGC commences Phase 1 of cannabinoid trial for Alzheimer's patients
- 08/11/20
- India Globalization gets FDA approval to initiate cannabinoid formulation study
- 01/05/21
- CV Sciences launches ProCBD product line
- 12/08/20
- CV Sciences enters common stock purchase agreement with Tumim Stone
- 11/24/20
- Cannabis stocks soar as Trump approves start of transition to Biden
- 11/04/20
- CV Sciences launches PlusCBD pet product line
- 01/08/21
- CannTrust launches new medical brand, estora
- 12/02/20
- CannTrust returns to Canadian marketplace with two recreational brands
- 08/06/20
- CannTrust says licenses reinstated for Vaughan Manufacturing Facility
- 10/05/20
- Cronos Group launches PEACE NATURALS brand in Israel
- 09/09/20
- Cronos Group appoints Kurt Schmidt as CEO
- 01/14/21
- Canopy Growth files early warning report regarding TerrAscend Corp.
- 01/07/21
- Constellation recognized $770M increase in fair value of Canopy investments
- 12/21/20
- Canopy Growth to have no interest in Canopy Rivers following Plan of Arrangement
- 12/21/20
- Canopy Growth announces plan of arrangement with Canopy Rivers
- 01/04/21
- General Cannabis raises over $2.9M of senior convertible promissory notes
- 09/14/20
- General Cannabis appoints Diane Jones as CFO
- $11.72 /
+1.715 (+17.15%) - 01/14/21
- Aphria jumps 6.5% to $10.65 after posting strong Q2 results
- 01/14/21
- Aphria CEO says 'we are pleased with our second quarter results'
- 12/16/20
- Aphria, Tilray announce $3.9B combination
- 12/16/20
- Aphria, Tilray confirm merger agreement with implied equity value of C$5B
- 01/06/21
- Aurora Cannabis rises 13.7%
- 01/06/21
- Aurora Cannabis rises 13.8%
- 12/16/20
- Aurora Cannabis provides business update, closing Aurora Sun facility
- 11/25/20
- Aurora Cannabis signs Israeli medical supply agreement with Cantek
- 12/04/20 Alliance Global Partners
- Alliance Global sees low odds of MORE Act passing this congressional session
- 12/02/20 Alliance Global Partners
- Alliance Global Partners sees UN cannabis reclassification helping legalization
- 08/31/20 Roth Capital
- Roth Capital believes MORE Act will not pass in 2020
- 06/12/20 Cowen
- CV Sciences initiated with a Market Perform at Cowen
- 01/06/21 BMO Capital
- Federal cannabis reform in U.S. likely to take time, says BMO Capital
- 01/05/21 Cantor Fitzgerald
- Canopy Growth price target raised to C$33 from C$29 at Cantor Fitzgerald
- 12/28/20 JPMorgan
- Constellation Brands price target raised to $248 from $218 at JPMorgan
- 12/24/20 Raymond James
- Raymond James says Village Farms situated well for cannabis sector consolidation
- $11.72 /
+1.715 (+17.15%) - 01/15/21 Alliance Global Partners
- Aphria price target raised to C$20 from C$12 at Alliance Global Partners
- 01/15/21 BMO Capital
- Aphria price target raised to C$15 from C$7 at BMO Capital
- 01/15/21 Canaccord
- Aphria upgraded to Speculative Buy from Hold at Canaccord
- 12/17/20 BMO Capital
- Aurora Cannabis downgraded to Underperform from Market Perform at BMO Capital
- 11/16/20 Jefferies
- Cronos Group price target lowered to C$5.00 from C$5.60 at Jefferies
- 04/08/20 Raymond James
- Ontario AG order positive for Canadian cannabis stocks, says Raymond James
IGC India Globalization Capital - $18.01 /
+2.985 (+19.87%) - 12/17/20 Canaccord
- Aphria downgraded to Hold from Speculative Buy at Canaccord
- 01/13/21 Canaccord
- Trulieve Cannabis price target raised to C$75 from C$60 at Canaccord
- 11/18/20 Craig-Hallum
- Trulieve Cannabis price target raised to $50 from $45 at Craig-Hallum
- 12/21/20 H.C. Wainwright
- Zynerba price target lowered to $9 from $12 at H.C. Wainwright
- 07/01/20 H.C. Wainwright
- Zynerba market cap 'greatly underprices' potential, says H.C. Wainwright
- 11/09/20
- Zynerba reports Q3 EPS (31c), consensus (43c)
- 08/10/20
- Zynerba reports Q2 EPS (78c), consensus (45c)
- $18.01 /
+2.985 (+19.87%) - 11/09/20
- Tilray sees positive or break even adjusted EBITDA in Q4
- 11/09/20
- Tilray reports Q3 EPS (2c), consensus (21c)
- 08/10/20
- Tilray reports Q2 EPS (66c), consensus (27c)
- 11/17/20
- Trulieve Cannabis reports Q3 EPS 15c
- 08/26/20
- Vireo Health reports Q2 adjusted net loss $7.4M versus loss of $4.1M in Q219
- 11/05/20
- Cronos Group reports Q3 revenue $11.36M vs. $5.79M a year ago
- 08/06/20
- Cronos Group reports Q2 EPS (31c) vs. 16c last year
- 01/07/21
- Constellation Brands reports Q3 adjusted EPS ex. Canopy $3.16, consensus $2.39
- 11/09/20
- Canopy Growth reports Q2 EPS (C$0.09) vs. C$0.25 last year
- 10/01/20
- Constellation Brands reports Q2 comparable EPS ex. Canopy Growth losses $2.91
- $11.72 /
+1.715 (+17.15%) - 01/14/21
- Aphria reports Q2 adjusted EPS C$0.01 vs. (C$0.19) a year ago
- 10/15/20
- Aphria reports Q1 EPS (C$0.02) vs. C$0.07 year ago
- 11/09/20
- Aurora Cannabis reports Q1 revenue C$67.8M vs. C$67.5M in Q4
- 10/30/20
- Aurora Cannabis sees Q1 revenue at high end of $60M-$64M previous guidance
- 09/22/20
- Aurora Cannabis sees Q1 revenue $60M-$64M vs. $67.5M in Q4
- 09/22/20
- Aurora Cannabis reports Q4 revenue $72.1M, a 5% decline from last quarter
|
Periodicals
|
Just as it appeared that… Just as it appeared that New Jersey Governor Phil Murphy's office and the state's legislature had reached a deal that would legalize marijuana in the Garden State, opposition from lawmakers has derailed the effort, NJ.com's Amanda Hoover reports. State Senator Nicholas Scutari, a Democrat who sponsored a "cleanup bill" to address the governor's call to add penalties for underage use of cannabis, said that the measure will not be put up to a vote in the full Senate on Monday after other senators objected to it, Hoover says. Murphy has declined to sign bills passed last month to legalize and decriminalize marijuana without changes that enact penalties for those under 21 caught with the substance, the author notes. Publicly traded companies in the space include Aphria (APHA), Aurora Cannabis (ACB), CV Sciences (CVSI), CannTrust Holdings (CNTTF), Canopy Growth (CGC), Cronos Group (CRON), General Cannabis (CANN), India Globalization Capital (IGC), Tilray (TLRY), Trulieve Cannabis (TCNNF) and Zynerba (ZYNE). Reference Link ShowHide Related Items >><< - 12/17/20
- Zynerba announces development plan for Zygel
- 12/17/20
- Zynerba provides regulatory update on Zygel in Fragile X syndrome
- 12/10/20
- Immunome appoints Richard Baron to board, Stoneman as Chief Legal Officer
- 12/16/20
- Aphria, Tilray announce $3.9B combination
- 12/16/20
- Aphria, Tilray confirm merger agreement with implied equity value of C$5B
- 12/15/20
- Tilray up 8%, Aphria up 2% after merger speculation reported by Bloomberg
- 12/02/20
- Tilray enters cannabis extracts co-promotion agreement with Hormosan in Germany
IGC India Globalization Capital - 11/24/20
- Cannabis stocks soar as Trump approves start of transition to Biden
- 11/23/20
- IGC commences Phase 1 of cannabinoid trial for Alzheimer's patients
- 11/23/20
- IGC commences Phase 1 of cannabinoid trial for Alzheimer's patients
- 08/11/20
- India Globalization gets FDA approval to initiate cannabinoid formulation study
- 01/05/21
- CV Sciences launches ProCBD product line
- 12/08/20
- CV Sciences enters common stock purchase agreement with Tumim Stone
- 11/04/20
- CV Sciences launches PlusCBD pet product line
- 10/05/20
- Cronos Group launches PEACE NATURALS brand in Israel
- 09/09/20
- Cronos Group appoints Kurt Schmidt as CEO
- 01/07/21
- Constellation recognized $770M increase in fair value of Canopy investments
- 12/21/20
- Canopy Growth to have no interest in Canopy Rivers following Plan of Arrangement
- 12/21/20
- Canopy Growth announces plan of arrangement with Canopy Rivers
- 12/10/20
- Canopy Growth, Arise Bioscience enter into $20M loan financing agreement
- 01/04/21
- General Cannabis raises over $2.9M of senior convertible promissory notes
- 09/14/20
- General Cannabis appoints Diane Jones as CFO
- 11/27/20
- Aphria expands 510 Vape offerings across adult-use brand portfolio
- 01/06/21
- Aurora Cannabis rises 13.7%
- 01/06/21
- Aurora Cannabis rises 13.8%
- 12/16/20
- Aurora Cannabis provides business update, closing Aurora Sun facility
- 11/25/20
- Aurora Cannabis signs Israeli medical supply agreement with Cantek
- 01/06/21 BMO Capital
- Federal cannabis reform in U.S. likely to take time, says BMO Capital
- 12/17/20 BMO Capital
- Aurora Cannabis downgraded to Underperform from Market Perform at BMO Capital
- 12/04/20 Alliance Global Partners
- Alliance Global sees low odds of MORE Act passing this congressional session
- 12/02/20 Alliance Global Partners
- Alliance Global Partners sees UN cannabis reclassification helping legalization
- 01/05/21 Cantor Fitzgerald
- Canopy Growth price target raised to C$33 from C$29 at Cantor Fitzgerald
- 12/28/20 JPMorgan
- Constellation Brands price target raised to $248 from $218 at JPMorgan
- 12/24/20 Raymond James
- Raymond James says Village Farms situated well for cannabis sector consolidation
IGC India Globalization Capital - 08/31/20 Roth Capital
- Roth Capital believes MORE Act will not pass in 2020
- 04/08/20 Raymond James
- Ontario AG order positive for Canadian cannabis stocks, says Raymond James
- 12/21/20 H.C. Wainwright
- Zynerba price target lowered to $9 from $12 at H.C. Wainwright
- 07/01/20 H.C. Wainwright
- Zynerba market cap 'greatly underprices' potential, says H.C. Wainwright
- 11/16/20 Jefferies
- Cronos Group price target lowered to C$5.00 from C$5.60 at Jefferies
- 12/17/20 Canaccord
- Aphria downgraded to Hold from Speculative Buy at Canaccord
- 12/17/20 Stifel
- Tilray upgraded to Hold from Sell at Stifel
- 12/17/20 Stifel
- Aphria downgraded to Hold from Buy at Stifel
- 06/12/20 Cowen
- CV Sciences initiated with a Market Perform at Cowen
- 12/17/20 CIBC
- Aphria price target raised to C$12.50 from C$9 at CIBC
- 11/18/20 Craig-Hallum
- Trulieve Cannabis price target raised to $50 from $45 at Craig-Hallum
- 11/17/20 Alliance Global Partners
- Trulieve Cannabis price target raised to C$50 from C$40 at Alliance Global
- 11/09/20
- Zynerba reports Q3 EPS (31c), consensus (43c)
- 08/10/20
- Zynerba reports Q2 EPS (78c), consensus (45c)
- 11/09/20
- Tilray sees positive or break even adjusted EBITDA in Q4
- 11/09/20
- Tilray reports Q3 EPS (2c), consensus (21c)
- 08/10/20
- Tilray reports Q2 EPS (66c), consensus (27c)
- 11/17/20
- Trulieve Cannabis reports Q3 EPS 15c
- 11/05/20
- Cronos Group reports Q3 revenue $11.36M vs. $5.79M a year ago
- 08/06/20
- Cronos Group reports Q2 EPS (31c) vs. 16c last year
- 01/07/21
- Constellation Brands reports Q3 adjusted EPS ex. Canopy $3.16, consensus $2.39
- 11/09/20
- Canopy Growth reports Q2 EPS (C$0.09) vs. C$0.25 last year
- 10/01/20
- Constellation Brands reports Q2 comparable EPS ex. Canopy Growth losses $2.91
- 08/26/20
- Vireo Health reports Q2 adjusted net loss $7.4M versus loss of $4.1M in Q219
- 10/15/20
- Aphria reports Q1 EPS (C$0.02) vs. C$0.07 year ago
- 11/09/20
- Aurora Cannabis reports Q1 revenue C$67.8M vs. C$67.5M in Q4
- 10/30/20
- Aurora Cannabis sees Q1 revenue at high end of $60M-$64M previous guidance
- 09/22/20
- Aurora Cannabis sees Q1 revenue $60M-$64M vs. $67.5M in Q4
- 09/22/20
- Aurora Cannabis reports Q4 revenue $72.1M, a 5% decline from last quarter
|
On The Fly
| ShowHide Related Items >><< - 12/17/20
- Zynerba announces development plan for Zygel
- 12/17/20
- Zynerba provides regulatory update on Zygel in Fragile X syndrome
- 12/10/20
- Immunome appoints Richard Baron to board, Stoneman as Chief Legal Officer
- 01/07/21
- WeedMD to exit Bowmanville facility in 2021
- 01/04/21
- WeedMD appoints George Scorsis as interim CEO
- 12/17/20
- WeedMD launches terpene-infused Saturday Cannabis-branded vape products
- 12/07/20
- WeedMD CCO Stephen NG to depart
- 11/06/20
- Curaleaf announces asset divestitures in Maryland to TerrAscend for $31.5M
- 12/15/20
- Tilray up 8%, Aphria up 2% after merger speculation reported by Bloomberg
- 12/02/20
- Tilray enters cannabis extracts co-promotion agreement with Hormosan in Germany
- 01/06/21
- MJardin Group enters supply agreement with BCLDB
- 12/22/20
- MJardin announces first shipment of recreational cannabis from Brampton facility
- 11/24/20
- MJardin Group terminates certain MSAs with parties located in Denver, Colorado
- 10/07/20
- MJardin Group executes MSA with Ontario Cannabis Store
IIPR Innovative Industrial Properties - 11/16/20
- Innovative Industrial Properties extends partnership with Kings Garden
- 09/21/20
- IIP acquires Florida property, expands real estate partnership with Parallel
- 09/15/20
- Innovative Industrial Properties raises Q3 dividend by 10% to $1.17 per share
- 09/03/20
- Innovative Industrial Properties exec chairman sells 15,000 common shares
- 01/07/21
- IntelGenx receives purchase order for CBD Filmstrips from Heritage
- 12/08/20
- IntelGenx announces issuance of shares in payment of interest on debentures
- 11/11/20
- IntelGenx issued U.S. patent for technology on cannabis-containing oral films
- 11/09/20
- IntelGenx announces publication of study evaluating Montelukast
IGC India Globalization Capital - 11/23/20
- IGC commences Phase 1 of cannabinoid trial for Alzheimer's patients
- 11/23/20
- IGC commences Phase 1 of cannabinoid trial for Alzheimer's patients
- 08/11/20
- India Globalization gets FDA approval to initiate cannabinoid formulation study
- 12/23/20
- Heritage Cannabis to acquire all of the securities of Premium 5
- 10/29/20
- IntelGenx signs LOI with Heritage Cannabis for Filmstrip supply agreement
- 10/07/20
- Heritage Cannabis products now offered on Patient Choice online platform
- 01/05/21
- CV Sciences launches ProCBD product line
- 12/08/20
- CV Sciences enters common stock purchase agreement with Tumim Stone
- 11/04/20
- CV Sciences launches PlusCBD pet product line
- 12/02/20
- CannTrust returns to Canadian marketplace with two recreational brands
- 08/06/20
- CannTrust says licenses reinstated for Vaughan Manufacturing Facility
- 10/05/20
- Cronos Group launches PEACE NATURALS brand in Israel
- 09/09/20
- Cronos Group appoints Kurt Schmidt as CEO
- 01/07/21
- Constellation recognized $770M increase in fair value of Canopy investments
- 12/21/20
- Canopy Growth to have no interest in Canopy Rivers following Plan of Arrangement
- 12/21/20
- Canopy Growth announces plan of arrangement with Canopy Rivers
- 12/10/20
- Canopy Growth, Arise Bioscience enter into $20M loan financing agreement
- 01/04/21
- General Cannabis raises over $2.9M of senior convertible promissory notes
- 09/14/20
- General Cannabis appoints Diane Jones as CFO
- 12/16/20
- Aphria, Tilray announce $3.9B combination
- 12/16/20
- Aphria, Tilray confirm merger agreement with implied equity value of C$5B
- 11/27/20
- Aphria expands 510 Vape offerings across adult-use brand portfolio
- 11/24/20
- Cannabis stocks soar as Trump approves start of transition to Biden
- 12/21/20
- Acreage Holdings files restated interim financial statements
- 12/18/20
- Acreage Holdings appoints Peter Caldini as CEO
- 11/03/20
- Acreage Holdings announces senior secured term loan facility
- 10/19/20
- Acreage Holdings announces retirement of shor-term strategic financing
- 01/06/21
- Aurora Cannabis rises 13.7%
- 01/06/21
- Aurora Cannabis rises 13.8%
- 12/16/20
- Aurora Cannabis provides business update, closing Aurora Sun facility
- 11/25/20
- Aurora Cannabis signs Israeli medical supply agreement with Cantek
- 01/06/21 BMO Capital
- Federal cannabis reform in U.S. likely to take time, says BMO Capital
- 01/05/21 Cantor Fitzgerald
- Canopy Growth price target raised to C$33 from C$29 at Cantor Fitzgerald
- 12/28/20 JPMorgan
- Constellation Brands price target raised to $248 from $218 at JPMorgan
- 12/24/20 Raymond James
- Raymond James says Village Farms situated well for cannabis sector consolidation
- 02/14/20 Cantor Fitzgerald
- Cantor initiates 10 cannabis names, sees opportunity after sellofff
- 02/13/20 Cantor Fitzgerald
- Acreage Holdings initiated with a Neutral at Cantor Fitzgerald
- 01/08/21 Cantor Fitzgerald
- TerrAscend initiated with an Overweight at Cantor Fitzgerald
- 12/21/20 Clarus
- TerrAscend price target raised to C$13.50 from C$12.75 at Clarus
- 12/16/20 Clarus
- TerrAscend resumed with a Buy at Clarus
- 08/25/20 Needham
- TerrAscend initiated with a Buy at Needham
IIPR Innovative Industrial Properties - 01/07/21 BTIG
- Innovative Industrial Properties price target raised to $218 from $177 at BTIG
- 12/23/20 Ladenburg
- Innovative Industrial Properties downgraded to Neutral from Buy at Ladenburg
- 12/23/20 Piper Sandler
- Innovative Industrial price target raised to $250 from $160 at Piper Sandler
- 12/18/20 Compass Point
- Innovative Industrial price target raised to $220 from $180 at Compass Point
- 12/17/20 CIBC
- Aphria price target raised to C$12.50 from C$9 at CIBC
- 12/17/20 Canaccord
- Aphria downgraded to Hold from Speculative Buy at Canaccord
- 12/17/20 BMO Capital
- Aurora Cannabis downgraded to Underperform from Market Perform at BMO Capital
- 12/04/20 Alliance Global Partners
- Alliance Global sees low odds of MORE Act passing this congressional session
- 12/02/20 Alliance Global Partners
- Alliance Global Partners sees UN cannabis reclassification helping legalization
- 08/31/20 Roth Capital
- Roth Capital believes MORE Act will not pass in 2020
- 06/12/20 Cowen
- CV Sciences initiated with a Market Perform at Cowen
- 11/16/20 Jefferies
- Cronos Group price target lowered to C$5.00 from C$5.60 at Jefferies
- 04/08/20 Raymond James
- Ontario AG order positive for Canadian cannabis stocks, says Raymond James
IGC India Globalization Capital - 12/17/20 Stifel
- Tilray upgraded to Hold from Sell at Stifel
- 12/17/20 Stifel
- Aphria downgraded to Hold from Buy at Stifel
- 11/18/20 Craig-Hallum
- Trulieve Cannabis price target raised to $50 from $45 at Craig-Hallum
- 11/17/20 Alliance Global Partners
- Trulieve Cannabis price target raised to C$50 from C$40 at Alliance Global
- 12/21/20 H.C. Wainwright
- Zynerba price target lowered to $9 from $12 at H.C. Wainwright
- 07/01/20 H.C. Wainwright
- Zynerba market cap 'greatly underprices' potential, says H.C. Wainwright
- 11/09/20
- Zynerba reports Q3 EPS (31c), consensus (43c)
- 08/10/20
- Zynerba reports Q2 EPS (78c), consensus (45c)
- 11/09/20
- Tilray sees positive or break even adjusted EBITDA in Q4
- 11/09/20
- Tilray reports Q3 EPS (2c), consensus (21c)
- 08/10/20
- Tilray reports Q2 EPS (66c), consensus (27c)
- 11/17/20
- Trulieve Cannabis reports Q3 EPS 15c
- 11/05/20
- MJardin Group reports Q3 revenue C$4.8M vs. C$7.6M last year
- 08/06/20
- MJardin Group reports Q1 revenue C$2.1M vs. C$6.88M last year
- 07/14/20
- MJardin Group reports Q1 revenue C$2.2M vs. C$10.78M last year
IIPR Innovative Industrial Properties - 11/04/20
- Innovative Industrial Properties reports Q3 FFO $1.28, consensus $1.16
- 08/05/20
- Innovative Industrial Properties reports Q2 adjusted FFO $1.19, consensus $1.22
- 11/05/20
- Cronos Group reports Q3 revenue $11.36M vs. $5.79M a year ago
- 08/06/20
- Cronos Group reports Q2 EPS (31c) vs. 16c last year
- 01/07/21
- Constellation Brands reports Q3 adjusted EPS ex. Canopy $3.16, consensus $2.39
- 11/09/20
- Canopy Growth reports Q2 EPS (C$0.09) vs. C$0.25 last year
- 10/01/20
- Constellation Brands reports Q2 comparable EPS ex. Canopy Growth losses $2.91
- 08/26/20
- Vireo Health reports Q2 adjusted net loss $7.4M versus loss of $4.1M in Q219
- 10/15/20
- Aphria reports Q1 EPS (C$0.02) vs. C$0.07 year ago
- 11/09/20
- Aurora Cannabis reports Q1 revenue C$67.8M vs. C$67.5M in Q4
- 10/30/20
- Aurora Cannabis sees Q1 revenue at high end of $60M-$64M previous guidance
- 09/22/20
- Aurora Cannabis sees Q1 revenue $60M-$64M vs. $67.5M in Q4
- 09/22/20
- Aurora Cannabis reports Q4 revenue $72.1M, a 5% decline from last quarter
|
Periodicals
|
New York lawmakers… New York lawmakers representing nearly a third of the state Senate on Tuesday pre-filed a bill to legalize marijuana, Marijuana Moments' Kyle Jaeger reports. Sen. Liz Krueger and 18 co-sponsors filed the legislation, which is identical to a bill she sponsored last year and has now been referred to the Senate Finance Committee, the author notes. It would make it so adults 21 and older would be able to purchase cannabis and cultivate up to six plants for personal use, the publication adds. Publicly traded companies in the space include Aphria (APHA), Aurora Cannabis (ACB), CV Sciences (CVSI), CannTrust Holdings (CNTTF), Canopy Growth (CGC), Cronos Group (CRON), General Cannabis (CANN), India Globalization Capital (IGC), Tilray (TLRY), Trulieve Cannabis (TCNNF) and Zynerba (ZYNE).Reference Link ShowHide Related Items >><< - 12/17/20
- Zynerba announces development plan for Zygel
- 12/17/20
- Zynerba provides regulatory update on Zygel in Fragile X syndrome
- 12/10/20
- Immunome appoints Richard Baron to board, Stoneman as Chief Legal Officer
- 12/16/20
- Aphria, Tilray announce $3.9B combination
- 12/16/20
- Aphria, Tilray confirm merger agreement with implied equity value of C$5B
- 12/15/20
- Tilray up 8%, Aphria up 2% after merger speculation reported by Bloomberg
- 12/02/20
- Tilray enters cannabis extracts co-promotion agreement with Hormosan in Germany
IGC India Globalization Capital - 11/24/20
- Cannabis stocks soar as Trump approves start of transition to Biden
- 11/23/20
- IGC commences Phase 1 of cannabinoid trial for Alzheimer's patients
- 11/23/20
- IGC commences Phase 1 of cannabinoid trial for Alzheimer's patients
- 08/11/20
- India Globalization gets FDA approval to initiate cannabinoid formulation study
- 01/05/21
- CV Sciences launches ProCBD product line
- 12/08/20
- CV Sciences enters common stock purchase agreement with Tumim Stone
- 11/04/20
- CV Sciences launches PlusCBD pet product line
- 10/05/20
- Cronos Group launches PEACE NATURALS brand in Israel
- 09/09/20
- Cronos Group appoints Kurt Schmidt as CEO
- 12/21/20
- Canopy Growth to have no interest in Canopy Rivers following Plan of Arrangement
- 12/21/20
- Canopy Growth announces plan of arrangement with Canopy Rivers
- 12/10/20
- Canopy Growth, Arise Bioscience enter into $20M loan financing agreement
- 12/09/20
- Canopy Growth says closures 'step towards achieving' $150M-$200M in cost savings
- 01/04/21
- General Cannabis raises over $2.9M of senior convertible promissory notes
- 09/14/20
- General Cannabis appoints Diane Jones as CFO
- 11/27/20
- Aphria expands 510 Vape offerings across adult-use brand portfolio
- 12/16/20
- Aurora Cannabis provides business update, closing Aurora Sun facility
- 11/25/20
- Aurora Cannabis signs Israeli medical supply agreement with Cantek
- 11/24/20
- Aurora Cannabis rises 22.1%
- 11/24/20
- Aurora Cannabis rises 22.8%
- 12/17/20 BMO Capital
- Aurora Cannabis downgraded to Underperform from Market Perform at BMO Capital
- 12/04/20 Alliance Global Partners
- Alliance Global sees low odds of MORE Act passing this congressional session
- 12/02/20 Alliance Global Partners
- Alliance Global Partners sees UN cannabis reclassification helping legalization
- 11/17/20 GLJ Research
- With $0 target, GLJ says short Aurora Cannabis on recent rally
- 01/05/21 Cantor Fitzgerald
- Canopy Growth price target raised to C$33 from C$29 at Cantor Fitzgerald
- 12/28/20 JPMorgan
- Constellation Brands price target raised to $248 from $218 at JPMorgan
- 12/24/20 Raymond James
- Raymond James says Village Farms situated well for cannabis sector consolidation
IGC India Globalization Capital - 08/31/20 Roth Capital
- Roth Capital believes MORE Act will not pass in 2020
- 04/08/20 Raymond James
- Ontario AG order positive for Canadian cannabis stocks, says Raymond James
- 12/21/20 H.C. Wainwright
- Zynerba price target lowered to $9 from $12 at H.C. Wainwright
- 07/01/20 H.C. Wainwright
- Zynerba market cap 'greatly underprices' potential, says H.C. Wainwright
- 11/16/20 Jefferies
- Cronos Group price target lowered to C$5.00 from C$5.60 at Jefferies
- 09/09/20 Stifel
- Cronos CEO transition 'natural part' of company's evolution, says Stifel
- 12/17/20 Canaccord
- Aphria downgraded to Hold from Speculative Buy at Canaccord
- 12/17/20 Stifel
- Tilray upgraded to Hold from Sell at Stifel
- 12/17/20 Stifel
- Aphria downgraded to Hold from Buy at Stifel
- 06/12/20 Cowen
- CV Sciences initiated with a Market Perform at Cowen
- 12/17/20 CIBC
- Aphria price target raised to C$12.50 from C$9 at CIBC
- 11/18/20 Craig-Hallum
- Trulieve Cannabis price target raised to $50 from $45 at Craig-Hallum
- 11/17/20 Alliance Global Partners
- Trulieve Cannabis price target raised to C$50 from C$40 at Alliance Global
- 11/09/20
- Zynerba reports Q3 EPS (31c), consensus (43c)
- 08/10/20
- Zynerba reports Q2 EPS (78c), consensus (45c)
- 11/09/20
- Tilray sees positive or break even adjusted EBITDA in Q4
- 11/09/20
- Tilray reports Q3 EPS (2c), consensus (21c)
- 08/10/20
- Tilray reports Q2 EPS (66c), consensus (27c)
- 11/17/20
- Trulieve Cannabis reports Q3 EPS 15c
- 11/05/20
- Cronos Group reports Q3 revenue $11.36M vs. $5.79M a year ago
- 08/06/20
- Cronos Group reports Q2 EPS (31c) vs. 16c last year
- 11/09/20
- Canopy Growth reports Q2 EPS (C$0.09) vs. C$0.25 last year
- 10/01/20
- Constellation Brands reports Q2 comparable EPS ex. Canopy Growth losses $2.91
- 08/26/20
- Vireo Health reports Q2 adjusted net loss $7.4M versus loss of $4.1M in Q219
- 08/10/20
- Canopy Growth reports Q2 EPS (C30c) vs. (C54c) last year
- 10/15/20
- Aphria reports Q1 EPS (C$0.02) vs. C$0.07 year ago
- 11/09/20
- Aurora Cannabis reports Q1 revenue C$67.8M vs. C$67.5M in Q4
- 10/30/20
- Aurora Cannabis sees Q1 revenue at high end of $60M-$64M previous guidance
- 09/22/20
- Aurora Cannabis sees Q1 revenue $60M-$64M vs. $67.5M in Q4
- 09/22/20
- Aurora Cannabis reports Q4 revenue $72.1M, a 5% decline from last quarter
|
Over a month ago |
On The Fly
| ShowHide Related Items >><< - 12/17/20
- Zynerba announces development plan for Zygel
- 12/17/20
- Zynerba provides regulatory update on Zygel in Fragile X syndrome
- 12/10/20
- Immunome appoints Richard Baron to board, Stoneman as Chief Legal Officer
- 12/15/20
- Tilray up 8%, Aphria up 2% after merger speculation reported by Bloomberg
- 12/02/20
- Tilray enters cannabis extracts co-promotion agreement with Hormosan in Germany
IGC India Globalization Capital - 11/23/20
- IGC commences Phase 1 of cannabinoid trial for Alzheimer's patients
- 11/23/20
- IGC commences Phase 1 of cannabinoid trial for Alzheimer's patients
- 08/11/20
- India Globalization gets FDA approval to initiate cannabinoid formulation study
- 12/08/20
- CV Sciences enters common stock purchase agreement with Tumim Stone
- 11/04/20
- CV Sciences launches PlusCBD pet product line
- 10/06/20
- CV Sciences announces PlusCBD brand refresh, new product launches
- 12/02/20
- CannTrust returns to Canadian marketplace with two recreational brands
- 08/06/20
- CannTrust says licenses reinstated for Vaughan Manufacturing Facility
- 06/25/20
- Banking lobbyists push for 'safe harbor' on cannabis in stimulus bill, FBN says
- 10/05/20
- Cronos Group launches PEACE NATURALS brand in Israel
- 09/09/20
- Cronos Group appoints Kurt Schmidt as CEO
- 12/21/20
- Canopy Growth to have no interest in Canopy Rivers following Plan of Arrangement
- 12/21/20
- Canopy Growth announces plan of arrangement with Canopy Rivers
- 12/10/20
- Canopy Growth, Arise Bioscience enter into $20M loan financing agreement
- 12/09/20
- Canopy Growth says closures 'step towards achieving' $150M-$200M in cost savings
- 09/14/20
- General Cannabis appoints Diane Jones as CFO
- 12/16/20
- Aphria, Tilray announce $3.9B combination
- 12/16/20
- Aphria, Tilray confirm merger agreement with implied equity value of C$5B
- 11/27/20
- Aphria expands 510 Vape offerings across adult-use brand portfolio
- 11/24/20
- Cannabis stocks soar as Trump approves start of transition to Biden
- 12/16/20
- Aurora Cannabis provides business update, closing Aurora Sun facility
- 11/25/20
- Aurora Cannabis signs Israeli medical supply agreement with Cantek
- 11/24/20
- Aurora Cannabis rises 22.1%
- 11/24/20
- Aurora Cannabis rises 22.8%
- 12/17/20 CIBC
- Aphria price target raised to C$12.50 from C$9 at CIBC
- 12/17/20 Canaccord
- Aphria downgraded to Hold from Speculative Buy at Canaccord
- 12/17/20 Stifel
- Tilray upgraded to Hold from Sell at Stifel
- 12/17/20 Stifel
- Aphria downgraded to Hold from Buy at Stifel
- 12/17/20 BMO Capital
- Aurora Cannabis downgraded to Underperform from Market Perform at BMO Capital
- 12/04/20 Alliance Global Partners
- Alliance Global sees low odds of MORE Act passing this congressional session
- 12/02/20 Alliance Global Partners
- Alliance Global Partners sees UN cannabis reclassification helping legalization
- 11/17/20 GLJ Research
- With $0 target, GLJ says short Aurora Cannabis on recent rally
- 08/31/20 Roth Capital
- Roth Capital believes MORE Act will not pass in 2020
- 06/12/20 Cowen
- CV Sciences initiated with a Market Perform at Cowen
- 11/30/20 BofA
- Canopy Growth price target raised to C$42 from C$36 at BofA
- 11/16/20 Jefferies
- Canopy Growth price target raised to $21.10 from $16 at Jefferies
- 11/16/20 Jefferies
- Cronos Group price target lowered to C$5.00 from C$5.60 at Jefferies
- 09/09/20 Stifel
- Cronos CEO transition 'natural part' of company's evolution, says Stifel
- 04/08/20 Raymond James
- Ontario AG order positive for Canadian cannabis stocks, says Raymond James
- 12/16/20 Alliance Global Partners
- Aphria price target raised to C$12 from C$9 at Alliance Global Partners
IGC India Globalization Capital - 11/18/20 Craig-Hallum
- Trulieve Cannabis price target raised to $50 from $45 at Craig-Hallum
- 11/17/20 Alliance Global Partners
- Trulieve Cannabis price target raised to C$50 from C$40 at Alliance Global
- 12/21/20 H.C. Wainwright
- Zynerba price target lowered to $9 from $12 at H.C. Wainwright
- 07/01/20 H.C. Wainwright
- Zynerba market cap 'greatly underprices' potential, says H.C. Wainwright
- 11/09/20
- Zynerba reports Q3 EPS (31c), consensus (43c)
- 08/10/20
- Zynerba reports Q2 EPS (78c), consensus (45c)
- 11/09/20
- Tilray sees positive or break even adjusted EBITDA in Q4
- 11/09/20
- Tilray reports Q3 EPS (2c), consensus (21c)
- 08/10/20
- Tilray reports Q2 EPS (66c), consensus (27c)
- 11/17/20
- Trulieve Cannabis reports Q3 EPS 15c
- 11/05/20
- Cronos Group reports Q3 revenue $11.36M vs. $5.79M a year ago
- 08/06/20
- Cronos Group reports Q2 EPS (31c) vs. 16c last year
- 11/09/20
- Canopy Growth reports Q2 EPS (C$0.09) vs. C$0.25 last year
- 10/01/20
- Constellation Brands reports Q2 comparable EPS ex. Canopy Growth losses $2.91
- 08/10/20
- Canopy Growth reports Q2 EPS (C30c) vs. (C54c) last year
- 10/15/20
- Aphria reports Q1 EPS (C$0.02) vs. C$0.07 year ago
- 08/26/20
- Vireo Health reports Q2 adjusted net loss $7.4M versus loss of $4.1M in Q219
- 11/09/20
- Aurora Cannabis reports Q1 revenue C$67.8M vs. C$67.5M in Q4
- 10/30/20
- Aurora Cannabis sees Q1 revenue at high end of $60M-$64M previous guidance
- 09/22/20
- Aurora Cannabis sees Q1 revenue $60M-$64M vs. $67.5M in Q4
- 09/22/20
- Aurora Cannabis reports Q4 revenue $72.1M, a 5% decline from last quarter
|
Periodicals
|
New Jersey lawmakers… New Jersey lawmakers passed a historic bill that establishes rules and regulations for legal cannabis sales and makes the Garden State the first in the region to overhaul its pot laws, NJ Advance Media's Amanda Hoover writes in a NJ.com article. The state Assembly voted 49-24 with six abstentions to pass the bill, and the Senate followed later Thursday, passing it 23-17, the author notes, adding that the bill now goes to Gov. Phil Murphy's desk, who must sign the measure for it to become law. In addition to passing the 240-page landmark legislation, lawmakers were scheduled to vote to end arrests for possessing less than six ounces of marijuana or selling up to an ounce and to lessen penalties for those caught with psilocybin, or "magic" mushrooms, the publication says. Publicly traded companies in the space include Aphria (APHA), Aurora Cannabis (ACB), CV Sciences (CVSI), CannTrust Holdings (CNTTF), Canopy Growth (CGC), Cronos Group (CRON), General Cannabis (CANN), India Globalization Capital (IGC), Tilray (TLRY), Trulieve Cannabis (TCNNF) and Zynerba (ZYNE).Reference Link ShowHide Related Items >><< - 12/17/20
- Zynerba announces development plan for Zygel
- 12/17/20
- Zynerba provides regulatory update on Zygel in Fragile X syndrome
- 12/10/20
- Immunome appoints Richard Baron to board, Stoneman as Chief Legal Officer
- 12/16/20
- Aphria, Tilray announce $3.9B combination
- 12/16/20
- Aphria, Tilray confirm merger agreement with implied equity value of C$5B
- 12/15/20
- Tilray up 8%, Aphria up 2% after merger speculation reported by Bloomberg
- 12/02/20
- Tilray enters cannabis extracts co-promotion agreement with Hormosan in Germany
IGC India Globalization Capital - 11/23/20
- IGC commences Phase 1 of cannabinoid trial for Alzheimer's patients
- 11/23/20
- IGC commences Phase 1 of cannabinoid trial for Alzheimer's patients
- 08/11/20
- India Globalization gets FDA approval to initiate cannabinoid formulation study
- 12/08/20
- CV Sciences enters common stock purchase agreement with Tumim Stone
- 11/04/20
- CV Sciences launches PlusCBD pet product line
- 10/06/20
- CV Sciences announces PlusCBD brand refresh, new product launches
- 10/05/20
- Cronos Group launches PEACE NATURALS brand in Israel
- 09/09/20
- Cronos Group appoints Kurt Schmidt as CEO
- 12/10/20
- Canopy Growth, Arise Bioscience enter into $20M loan financing agreement
- 12/09/20
- Canopy Growth says closures 'step towards achieving' $150M-$200M in cost savings
- 12/09/20
- Canopy Growth to cease operations at several sites, impacting 220 employees
- 11/24/20
- Cannabis stocks soar as Trump approves start of transition to Biden
- 09/14/20
- General Cannabis appoints Diane Jones as CFO
- 06/25/20
- Banking lobbyists push for 'safe harbor' on cannabis in stimulus bill, FBN says
- 11/27/20
- Aphria expands 510 Vape offerings across adult-use brand portfolio
- 12/16/20
- Aurora Cannabis provides business update, closing Aurora Sun facility
- 11/25/20
- Aurora Cannabis signs Israeli medical supply agreement with Cantek
- 11/24/20
- Aurora Cannabis rises 22.1%
- 11/24/20
- Aurora Cannabis rises 22.8%
- 12/04/20 Alliance Global Partners
- Alliance Global sees low odds of MORE Act passing this congressional session
- 12/02/20 Alliance Global Partners
- Alliance Global Partners sees UN cannabis reclassification helping legalization
- 11/17/20 GLJ Research
- With $0 target, GLJ says short Aurora Cannabis on recent rally
- 11/16/20
- Fly Intel: Top five analyst downgrades
- 11/30/20 BofA
- Canopy Growth price target raised to C$42 from C$36 at BofA
- 11/16/20 Jefferies
- Canopy Growth price target raised to $21.10 from $16 at Jefferies
IGC India Globalization Capital - 08/31/20 Roth Capital
- Roth Capital believes MORE Act will not pass in 2020
- 04/08/20 Raymond James
- Ontario AG order positive for Canadian cannabis stocks, says Raymond James
- 07/01/20 H.C. Wainwright
- Zynerba market cap 'greatly underprices' potential, says H.C. Wainwright
- 07/01/20 Canaccord
- Zynerba price target lowered to $12 from $18 at Canaccord
- 11/16/20 Jefferies
- Cronos Group price target lowered to C$5.00 from C$5.60 at Jefferies
- 09/09/20 Stifel
- Cronos CEO transition 'natural part' of company's evolution, says Stifel
- 12/17/20 Canaccord
- Aphria downgraded to Hold from Speculative Buy at Canaccord
- 12/17/20 Stifel
- Tilray upgraded to Hold from Sell at Stifel
- 12/17/20 Stifel
- Aphria downgraded to Hold from Buy at Stifel
- 12/16/20 Alliance Global Partners
- Aphria price target raised to C$12 from C$9 at Alliance Global Partners
- 06/12/20 Cowen
- CV Sciences initiated with a Market Perform at Cowen
- 12/17/20 CIBC
- Aphria price target raised to C$12.50 from C$9 at CIBC
- 11/18/20 Craig-Hallum
- Trulieve Cannabis price target raised to $50 from $45 at Craig-Hallum
- 11/17/20 Alliance Global Partners
- Trulieve Cannabis price target raised to C$50 from C$40 at Alliance Global
- 11/09/20
- Zynerba reports Q3 EPS (31c), consensus (43c)
- 08/10/20
- Zynerba reports Q2 EPS (78c), consensus (45c)
- 11/09/20
- Tilray sees positive or break even adjusted EBITDA in Q4
- 11/09/20
- Tilray reports Q3 EPS (2c), consensus (21c)
- 08/10/20
- Tilray reports Q2 EPS (66c), consensus (27c)
- 11/17/20
- Trulieve Cannabis reports Q3 EPS 15c
- 11/05/20
- Cronos Group reports Q3 revenue $11.36M vs. $5.79M a year ago
- 08/06/20
- Cronos Group reports Q2 EPS (31c) vs. 16c last year
- 11/09/20
- Canopy Growth reports Q2 EPS (C$0.09) vs. C$0.25 last year
- 10/01/20
- Constellation Brands reports Q2 comparable EPS ex. Canopy Growth losses $2.91
- 08/26/20
- Vireo Health reports Q2 adjusted net loss $7.4M versus loss of $4.1M in Q219
- 08/10/20
- Canopy Growth reports Q2 EPS (C30c) vs. (C54c) last year
- 10/15/20
- Aphria reports Q1 EPS (C$0.02) vs. C$0.07 year ago
- 11/09/20
- Aurora Cannabis reports Q1 revenue C$67.8M vs. C$67.5M in Q4
- 10/30/20
- Aurora Cannabis sees Q1 revenue at high end of $60M-$64M previous guidance
- 09/22/20
- Aurora Cannabis sees Q1 revenue $60M-$64M vs. $67.5M in Q4
- 09/22/20
- Aurora Cannabis reports Q4 revenue $72.1M, a 5% decline from last quarter
|